Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK MHRA Hones In On 'Medical Purpose' In Software And Apps Guidance

Executive Summary

Updated UK guidance on medical device standalone software and apps provides much more clarification on what “medical purpose” means.

You may also be interested in...



Registrations For Medical App-Makers Double In UK, But Noncompliance Still High

While UK guidance on standalone software has clarified how to differentiate lifestyle or wellbeing apps from those that fall under the EU directives governing medical devices and IVDs, many manufacturers are still unaware of the rules and are operating without being properly registered.

European Commission Revises Device Software Guidance But Is "Almost Silent" On Mobile Apps

The only notable changes in the revised EU guideline on standalone software used in healthcare settings is the addition of definitions for new terms like software, and input and output data.

EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions

After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT103792

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel